Antiplatelet Therapy Monitoring in Neonates and Children.


Journal

Seminars in thrombosis and hemostasis
ISSN: 1098-9064
Titre abrégé: Semin Thromb Hemost
Pays: United States
ID NLM: 0431155

Informations de publication

Date de publication:
Feb 2019
Historique:
pubmed: 20 12 2018
medline: 21 3 2019
entrez: 20 12 2018
Statut: ppublish

Résumé

Antiplatelet agents are used for the prevention and treatment of thromboembolic disease in an increasingly complex population of pediatric patients. Despite their importance for clinical outcome, there is no consensus on the most effective monitoring strategies. This review describes the current state of knowledge focusing on antiplatelet therapy monitoring in children. The authors searched five databases (PubMed-NCBI, MEDLINE-OVID, SCOPUS-Elsevier, ScienceDirect, and Cochrane) from January 2000 to October 2017 using keywords selected

Identifiants

pubmed: 30566968
doi: 10.1055/s-0038-1676375
doi:

Substances chimiques

Platelet Aggregation Inhibitors 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

73-85

Informations de copyright

Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Déclaration de conflit d'intérêts

None.

Auteurs

Joanna Yilin Huang (JY)

School of Clinical Sciences, Monash University, Clayton, Victoria, Australia.
Hematology Research Group, Murdoch Children's Research Institute, Parkville, Victoria, Australia.
Department of Clinical Hematology, Royal Children's Hospital, Parkville, Victoria, Australia.

Diajeng Ayesha Soeharto (DA)

Faculty of Medicine, Dentistry, and Health Sciences, The University of Melbourne, Parkville, Victoria, Australia.
Faculty of Medicine, University of Indonesia, Jakarta, Indonesia.

Ivan Damara (I)

Faculty of Medicine, Dentistry, and Health Sciences, The University of Melbourne, Parkville, Victoria, Australia.
Faculty of Medicine, University of Indonesia, Jakarta, Indonesia.

Vera Ignjatovic (V)

Hematology Research Group, Murdoch Children's Research Institute, Parkville, Victoria, Australia.
Department of Pediatrics, The University of Melbourne, Parkville, Victoria, Australia.

Matthew D Linden (MD)

School of Biomedical Sciences, The University of Western Australia, Nedlands, Western Australia, Australia.

Paul Monagle (P)

Hematology Research Group, Murdoch Children's Research Institute, Parkville, Victoria, Australia.
Department of Clinical Hematology, Royal Children's Hospital, Parkville, Victoria, Australia.
Department of Pediatrics, The University of Melbourne, Parkville, Victoria, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH